疫苗经济学评估中更广泛社会价值结局的范围综述
该范围综述系统检索并综合了疫苗规划经济分析中报告的社会、经济与环境价值结局,共纳入171篇文章,识别出五类更广泛价值结局,包括短期和长期生产力影响、后遗症相关结局、自付费用及其他更广泛经济与社会影响。结论认为疫苗经济学评估仍低估疫苗多维价值,应扩大这些结局的纳入以支持更全面的免疫投资决策。
要点
- 疫苗经济评估常仅关注直接医疗成本与QALYs,可能低估疫苗全部价值。
- 综述识别五类更广泛价值结局:生产力、后遗症、自付费用等。
- 建议扩大更广泛社会、经济与全生命周期结局的纳入以优化决策。
核心结论
- 免疫规划的经济学评估仍未能充分代表疫苗接种的全多维价值,对更广泛社会、经济与全生命周期影响的纳入有限。
- 扩大这些结局的纳入将增强证据基础,并支持更明智、更全面的免疫投资决策。
研究设计与样本
- 范围综述,系统检索同行评议与灰色文献,检索获得8442条记录,全文筛选后纳入171篇文章。
主要发现
- 识别出五类更广泛价值结局:短期和长期生产力影响、后遗症相关结局(如长期照护需求)、自付费用及其他更广泛经济与社会影响。
临床怎么用
- 在疫苗经济学评估中应关注并纳入生产力影响、后遗症相关结局、自付费用等更广泛价值结局,以更全面评估免疫规划投资。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional economic evaluations typically focus on direct healthcare costs and quality-adjusted life years (QALYs), potentially underestimating the full value of vaccination. OBJECTIVE: This scoping review aimed to identify the broader outcomes captured in economic analyses of vaccination programmes. METHODS: A scoping review was conducted to explore the broader social, economic, and environmental values reported in economic analysis studies of vaccination programmes and strategies. Peer-reviewed and grey literature were systematically searched, and relevant studies were synthesised. RESULTS: A total of 8442 records were retrieved, with 171 articles included following full-text screening. Five categories of broader-value outcomes were identified, including short- and long-term productivity impacts, sequelae-related outcomes (e.g., long-term care needs), out-of-pocket expenses, and other wider economic and societal impacts. CONCLUSIONS: Economic evaluations of immunisation programmes continue to underrepresent the full multidimensional value of vaccination, with limited incorporation of broader social, economic, and life-course impacts. Expanding the inclusion of these outcomes will strengthen the evidence base and support more informed, holistic decision-making for immunisation investment.
引用
- Prendergast L, Begley E, Savoury M, et al. Exploring the broader social value outcomes reported in economic evaluations of vaccination programmes across the life course: A scoping review. Vaccine. 2026. PMID: 42858681. doi:10.1016/j.vaccine.2026.129226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。